Bausch Lomb Reports Q2 2025 Earnings with Revenue Growth and Segment Performance Details
Bausch Lomb (BLCO) reported Q2 2025 earnings with total company revenue of $1.278 billion, reflecting 3% year-over-year growth on a constant currency basis. Key segments showed mixed performance, with Vision Care up 6% and Surgical Segment growth impacted by a recall, while Pharmaceutical Segment revenue declined 1%. The company also highlighted strong growth in its Dry Eye Portfolio and contact lens categories.
Tickers: $BLCO
Topics: earnings report financial results revenue growth segment performance